Aging therapy using blood components
Total Trials
13
As Lead Sponsor
12
As Collaborator
1
Total Enrollment
510
NCT02256306
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study
Phase: N/A
Role: Collaborator
Start: Sep 30, 2014
Completion: Feb 28, 2017
NCT03558061
Evaluate the Effects and Safety of ALK4290 in Patients With Newly Diagnosed Wet Age-Related Macular Degeneration
Phase: Phase 2
Role: Lead Sponsor
Start: Apr 4, 2018
Completion: Nov 18, 2018
NCT03520998
A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Start: Apr 16, 2018
Completion: May 24, 2019
NCT03558074
Evaluate the Therapeutic Effects and Safety of ALK4290 in Patients With Refractory Wet Age-Related Macular Degeneration
Start: Apr 20, 2018
Completion: Nov 29, 2018
NCT03713957
A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment
Start: Nov 12, 2018
Completion: Jul 20, 2020
NCT03765762
A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease
Start: Jan 15, 2019
Completion: Dec 17, 2019
NCT03981419
A Study to Evaluate the Effect of GRF6021 on Postoperative Recovery Following Primary Hip or Knee Arthroplasty
Start: Jul 12, 2019
Completion: Mar 4, 2021
NCT04369430
Study Assessing Efficacy and Safety of AKST4290 in Subjects With Parkinson's Disease on Stable Dopaminergic Treatment
Start: Jan 16, 2020
Completion: Mar 10, 2021
NCT04331730
A Study to Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD
Start: Jan 28, 2020
Completion: Sep 16, 2021
NCT04499235
A Study to Assess the Therapeutic Effect and Safety of Adjunctive AKST4290 in Subjects With Bullous Pemphigoid
Start: Jan 30, 2020
Completion: Apr 14, 2021
NCT04527328
A Study to Assess the Tolerability and Efficacy of AKST1210 in Patients on Hemodialysis With Cognitive Impairment
Start: Apr 28, 2020
Completion: Jun 4, 2021
NCT04985383
Study to Compare Safety and Tolerability of AKST1210 Column at 2 Blood Flow Rates in Subjects With ESRD on Hemodialysis
Start: Mar 11, 2021
Completion: Sep 1, 2021
NCT05038020
A Study to Evaluate the Efficacy of Oral AKST4290 in Participants With Moderately Severe to Severe Diabetic Retinopathy (CAPRI)
Start: Aug 17, 2021
Completion: Apr 19, 2022
Loading map...